Phase 1 Bile Duct Cancer Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Intrahepatic CholangiocarcinomaGallbladder CarcinomaMetastatic Malignant Neoplasm in the Peritoneum+5 more
City of Hope Medical Center12 enrolled1 locationNCT05285358
Recruiting
Phase 1Phase 2
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
Biliary CancerBile Duct CancerCancer of the Bile Duct
National Cancer Institute (NCI)60 enrolled1 locationNCT05849480
Recruiting
Phase 1
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
Colorectal, CancerPancreatic CancerGastric Cancer+5 more
University Hospital, Ghent45 enrolled1 locationNCT05277766
Recruiting
Phase 1
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
Breast Cancer FemaleColorectal, CancerPancreatic Cancer+4 more
UTC Therapeutics Inc.24 enrolled1 locationNCT06256055
Recruiting
Phase 1
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
Breast CancerColorectal, CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd30 enrolled2 locationsNCT06043466